Medherant is a clinical-stage drug delivery company developing products for pain and CNS diseases. It provides a drug-in-adhesive transdermal delivery system, the TEPI Patch. The company also undertakes studies for other companies to investigate whether their drugs can be formulated for transdermal delivery using TEPI technology.